| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8739635 | Journal of Clinical Virology | 2018 | 5 Pages |
Abstract
Prevalence of HEV viraemia in SOT and HSCT patients in U.K. although higher than in the general population is low at baseline and remains low throughout the early post-transplant phase. Clearance of viraemia can be maintained despite ongoing immunosuppression. Prospective U.K. studies are necessary to inform screening policies in this population.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Ian Reekie, Dianne Irish, Samreen Ijaz, Thomas Fox, Tehmina Bharucha, Paul Griffiths, Douglas Thorburn, Mark Harber, Stephen MacKinnon, Mallika Sekhar,